Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation
Significance
Indoleamine 2,3-dioxygenase 1 (IDO1) is an immunoregulatory enzyme that transforms tryptophan into kynurenine, an endogenous agonist of the aryl hydrocarbon receptor (AhR) whose activation sustains IDO1 expression and activity over the long term in dendritic cells (DCs). Here we found that N -acetylserotonin (NAS), a tryptophan metabolite produced along the serotonin pathway, acts as a positive allosteric modulator (PAM) of IDO1 and thus increases kynurenine-mediated AhR activation in DCs. NAS effects on IDO1 translated into protection of mice from neuroinflammation and reinstallment of physiologic IDO1 activity in peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis.
Top-30
Journals
|
1
2
3
4
|
|
|
Frontiers in Immunology
4 publications, 5.41%
|
|
|
International Journal of Molecular Sciences
3 publications, 4.05%
|
|
|
Current Opinion in Immunology
3 publications, 4.05%
|
|
|
ChemMedChem
3 publications, 4.05%
|
|
|
International Journal of Tryptophan Research
2 publications, 2.7%
|
|
|
Cells
2 publications, 2.7%
|
|
|
Cancers
2 publications, 2.7%
|
|
|
Frontiers in Neuroscience
2 publications, 2.7%
|
|
|
Nature Communications
2 publications, 2.7%
|
|
|
Brain Behavior & Immunity - Health
2 publications, 2.7%
|
|
|
European Journal of Pharmacology
2 publications, 2.7%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
2 publications, 2.7%
|
|
|
International Immunopharmacology
2 publications, 2.7%
|
|
|
Cell Death and Disease
1 publication, 1.35%
|
|
|
Molecular Pharmacology
1 publication, 1.35%
|
|
|
Biomolecules
1 publication, 1.35%
|
|
|
Nutrients
1 publication, 1.35%
|
|
|
Clinical Oral Investigations
1 publication, 1.35%
|
|
|
Neuroscience
1 publication, 1.35%
|
|
|
Journal of Neuroinflammation
1 publication, 1.35%
|
|
|
Free Radical Biology and Medicine
1 publication, 1.35%
|
|
|
Trends in Immunology
1 publication, 1.35%
|
|
|
Journal of Autoimmunity
1 publication, 1.35%
|
|
|
Biochimica et Biophysica Acta - Molecular Basis of Disease
1 publication, 1.35%
|
|
|
Bioorganic Chemistry
1 publication, 1.35%
|
|
|
Pharmacology and Therapeutics
1 publication, 1.35%
|
|
|
Trends in Molecular Medicine
1 publication, 1.35%
|
|
|
FEBS Journal
1 publication, 1.35%
|
|
|
Journal of Clinical Laboratory Analysis
1 publication, 1.35%
|
|
|
1
2
3
4
|
Publishers
|
5
10
15
20
25
|
|
|
Elsevier
23 publications, 31.08%
|
|
|
MDPI
9 publications, 12.16%
|
|
|
Frontiers Media S.A.
9 publications, 12.16%
|
|
|
Springer Nature
8 publications, 10.81%
|
|
|
Wiley
6 publications, 8.11%
|
|
|
SAGE
2 publications, 2.7%
|
|
|
American Chemical Society (ACS)
2 publications, 2.7%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
2 publications, 2.7%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
1 publication, 1.35%
|
|
|
BMJ
1 publication, 1.35%
|
|
|
IntechOpen
1 publication, 1.35%
|
|
|
Hindawi Limited
1 publication, 1.35%
|
|
|
Beijing University of Chinese Medicine
1 publication, 1.35%
|
|
|
eLife Sciences Publications
1 publication, 1.35%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 1.35%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 1.35%
|
|
|
IMR Press
1 publication, 1.35%
|
|
|
Taylor & Francis
1 publication, 1.35%
|
|
|
Ankara University
1 publication, 1.35%
|
|
|
S. Karger AG
1 publication, 1.35%
|
|
|
Apex Publishing
1 publication, 1.35%
|
|
|
5
10
15
20
25
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.